2021-04-26T07:59:18Z – Biohit Oyj comments on the claims presented in public by a member of Biohit board of directors, Mr. Liu Feng
2021-04-20T10:00:00Z – A study from Italy confirms: Low levels of G-17 biomarker of the Biohit GastroPanel® test predict the risk of esophagitis and esophageal reflux disease (GERD)
2021-04-08T10:00:00Z – Austell Pharmaceuticals starts as a new distributor of Biohit Oyj’s GastroPanel[®] test in South Africa
2021-03-26T13:35:00Z – Publication of Biohit Oyj Annual Report 2020
2021-03-26T07:01:02Z – Biohit’s CEO is on sick leave
2021-03-08T08:00:00Z – European Union and Business Finland provide Biohit Oyj with a total of EUR 900,000 in financing for product development
2021-03-03T15:00:00Z – Biohit Plc - Managers' transactions - Aiolfi
2021-03-03T15:00:00Z – Biohit Plc - Managers' transactions - Aiolfi
2021-02-23T08:02:16Z – Biohit Oyj Managers' Transactions
2021-02-17T07:30:00Z – Biohit group financial statement release 2020
2020-12-14T07:30:00Z – TPX Medik appointed as the exclusive distributor of GastroPanel® test in Malaysia
2020-12-09T12:30:00Z – Biohit Oyj’s Financial Reporting and Annual General Meeting in 2021
2020-09-25T12:00:00Z – Biohit GastroPanel[®] test was studied clinically in patients with autoimmune disease
2020-09-16T15:48:39Z – Correction: Decisions of the Annual General Meeting of Biohit Oyj
2020-09-16T15:00:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2020-09-16T12:30:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2020-08-21T14:30:00Z – Notice of Biohit oyj’s annual general meeting
2020-08-12T06:30:00Z – Biohit group half year financial report 2020
2020-08-06T07:05:00Z – The usefulness of Biohit GastroPanel[®] biomarkers in diagnosis of atrophic gastritis confirmed in a multi-center study in France
2020-06-04T15:00:00Z – Biohit Group’s Net Sales outlook for 2020 changed
2020-04-15T07:03:40Z – Does an undiagnosed atrophic gastritis (acid-free stomach) increase the risk of coronavirus infection, its complications and mortality particularly among elderly people?
2020-03-27T17:15:32Z – Correction: Biohit Oyj’s Annual Report 2019 is published
2020-03-27T16:24:28Z – Correction regarding the Stock exchange release: Biohit Oyj's 2020 Annual general meeting
2020-03-27T15:36:46Z – Publication of Biohit Oyj Annual Report 2019 and Renumeration Policy 2020
2020-03-27T15:00:00Z – Biohit oyj’s annual general meeting 2020
2020-03-12T08:00:00Z – Population-based screening by Biohit GastroPanel[®] biomarkers practically eliminates the risk of gastric cancer during a long-term follow-up
2020-02-19T07:30:00Z – Biohit Group Financial Statement Release 2019
2020-01-31T15:55:41Z – Biohit Plc - Managers' transactions - Aiolfi
2019-11-29T14:00:00Z – Biohit Oyj Financial Calendar, Biohit Oyj’s Financial Reporting and Annual General Meeting in 2020
2019-10-14T13:15:00Z – TREATMENT RECOMMENDATION IN RUSSIA: GastroPanel® biomarkers should be used for detection of gastrointestinal diseases
2019-08-14T06:30:00Z – BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
2019-08-09T12:30:00Z – Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
2019-06-12T10:15:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2019-06-03T09:15:00Z – Biohit Plc - Managers' transactions - Söderström
2019-05-20T07:30:00Z – May is the month for esophageal, intestinal and gastric health - How to prevent diseases and diagnose them early?
2019-04-25T06:30:00Z – Constitutive meeting of Biohit Oyj’s Board of Directors
2019-04-24T16:30:00Z – Decisions of the Annual General Meeting of Biohit Oyj
2019-04-17T06:30:00Z – Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
2019-04-11T06:30:00Z – Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019
2019-04-09T06:30:00Z – Biohit GastroPanel® biomarkers validated as powerful predictors of gastric cancer risk in a multicenter study
2019-04-04T06:30:00Z – Satya Abadi Pharma to distribute Acetium® lozenge in Indonesia
2019-03-29T07:30:00Z – Publication of Biohit Oyj Annual Report 2018
2019-03-29T07:30:00Z – Notice of Biohit Oyj’s Annual General Meeting
2019-03-25T07:30:00Z – Finns choose a domestic nicotine-free product as their preferred smoking intervention method
2019-02-27T11:30:00Z – Biohit Oyj B-shares Subscribed with Stock Options I 2013
2019-02-20T07:30:00Z – BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
2019-02-11T15:45:00Z – Biohit Oyj: Managers' Transactions
2019-02-04T12:26:23Z – International group of experts revisits the value of traditional Helicobacter tests (13C urea breath test and stool antigen test) in their critical review
2019-01-31T10:00:00Z – Business Development Director Lea Paloheimo will retire from Biohit Oyj
2019-01-28T12:30:27Z – Nicotine dependence is an increasing problem